G-20's Cash Infusion Boosts Markets To Higher Close

Optimism that the G-20's infusion of cash will end the global financial crisis boosted the markets to a sharply higher close with the Dow soaring 216 points to 7978. Nasdaq leaped 51 points to 1602.

On the upside

Juniper Networks (Nasdaq: JNPR) introduced its integrated video monitoring and analysis solution StreamScope.

The MoCA Certification Board awarded Broadcom's (Nasdaq: BRCM) home networking platform using Multimedia over Coax Alliance connectivity a MoCA Certification.

Rupert Murdoch, chairman of News Corp. (Nasdaq: NWS), said that newspapers need to charge for content in order to offset delining advertising revenue.

General Electric (NYSE: GE) partnered with Intel (Nasdaq: INTC) to develop patient monitoring devices that allow doctors to check on patients remotely.

On the downside

A Food and Drug Administration panel recommended approval for oral diabetes medication Onglyza developed by Bristol-Myers Squibb (NYSE: BMY) and AstraZeneca. Shares of Amylin (Nasdaq: AMLN), which makes the injectable diabetes drug Byetta, tumbled.

Navistar International (NYSE: NAV) filed a formal protest with the Pentagon over the government agency's evaluation process for a bid to supply mine-resistant ambush-protected vehicles for the military.


In the broad market, advancing issues outpaced decliners by a margin of 6 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks surged 21 points to 450.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.